Through this collaboration, Kent's SnapshotNIR and SnapshotGLO tissue assessment tools are paired with Marathon Medical's over two decades of expertise in serving the VA.
This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community.”— Pierre Lemire, CEO
CALGARY, AB – ALBERTA, CANADA, August 26, 2026 /EINPresswire.com/ — Kent Imaging Inc., a frontrunner in near-infrared tissue oxygenation and bacterial autofluorescence imaging, has unveiled a new alliance with Marathon Medical Corporation, a Service-Disabled Veteran-Owned Small Business (SDVOSB) focused on federal healthcare distribution. Together, the two entities will broaden the availability of Kent Imaging's cutting-edge wound imaging technologies at U.S. Department of Veterans Affairs (VA) healthcare sites, enabling clinicians to detect patients at risk for wound complications sooner and promote better results for America's Veterans.
The collaboration merges Kent Imaging's bedside tissue assessment devices, SnapshotNIR and SnapshotGLO, along with any forthcoming product innovations, with Marathon Medical's more than 20 years of experience supporting the VA, Department of Defense, and other federal health agencies. Established by Vietnam Veteran John St. Leger, Marathon Medical has centered its operations on assisting the federal healthcare system that serves those who have served the country.
Chronic wounds and lower extremity complications persist as a major health issue within the Veteran population, especially among individuals dealing with diabetes and peripheral arterial disease (PAD). By supplying clinicians with objective data on tissue oxygenation and bacterial load at the point of care, Kent Imaging’s solutions facilitate earlier clinical decisions that enhance healing outcomes and lower the rate of preventable amputations.
“This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community,” said Pierre Lemire, CEO of Kent Imaging. “We are proud to work with Marathon Medical to bring innovative imaging solutions to the clinicians who care for patients in need.”
“Echoing that commitment, this partnership gives us an opportunity to put that mission into action by expanding access to advanced wound imaging where it can make a meaningful difference in patient care,” adds Chris Tiemann, Vice President of Sales, Kent Imaging.
As a Service-Disabled Veteran-Owned Small Business, Marathon Medical is committed to providing top-tier medical products and tailored, professional service across the federal healthcare system. The company collaborates closely with VA hospitals, military treatment facilities, and other government entities to ensure providers have prompt access to innovative medical technologies.
"At Marathon Medical, our mission has always been to serve those who served. We are pleased to have Kent Imaging’s Snapshot suite as part of that mission," said Jon Landis, Chief Commercialization Officer, Marathon Medical.
This partnership highlights the shared dedication of both organizations to advancing Veteran Healthcare through innovation, while also strengthening ties between medical technology companies and veteran-owned businesses that serve the federal healthcare community.
About Kent Imaging
Headquartered in Calgary, Alberta, Canada, Kent Imaging is a premier innovator in advanced imaging technology. The company creates, manufactures, and markets medical devices that support real-time decision-making in wound care, vascular, and surgical fields. Through patented technologies, Kent continues to deliver pioneering solutions that assist healthcare systems worldwide.
The Snapshot product suite now comprises two robust imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017 and CE-marked in 2025; and SnapshotGLO, a bacterial autofluorescence imaging device that obtained FDA 510(k) clearance in 2025. SnapshotNIR is backed by clinical evidence showing its role in improving clinical decision-making, while SnapshotGLO offers real-time insight into wound bioburden presence and distribution. Together, the Snapshot product family strengthens clinicians' ability to detect, direct, and protect—promoting treatment consistency, supporting improved workflow, and contributing to better patient care worldwide.
SnapshotGLO® is a registered trademark of Kent Imaging Inc.
SnapshotNIR® is a registered trademark of Kent Imaging Inc.
About Marathon Medical
Founded in 2002, Marathon Medical Corporation is a Service-Disabled Veteran-Owned Small Business (SDVOSB) based in Aurora, Colorado. The company focuses on delivering medical products to the U.S. Department of Veterans Affairs, Department of Defense, and other federal healthcare agencies, with a goal of providing excellence in the healthcare supply chain through professional, personal service.
Leah Pavlick
Kent Imaging Inc.
leah@kentimaging.com
Visit us on social media:
LinkedIn
